BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16450506)

  • 1. Venous thromboembolism: which patients are truly at risk?
    Di Minno G; Agnes R; Tufano A
    Acta Biomed; 2005; 76 Suppl 1():31-2. PubMed ID: 16450506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of venous thromboembolism.
    Kearon C
    Semin Vasc Med; 2001; 1(1):7-26. PubMed ID: 15199510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients.
    Cohen AT; Alikhan R; Arcelus JI; Bergmann JF; Haas S; Merli GJ; Spyropoulos AC; Tapson VF; Turpie AG
    Thromb Haemost; 2005 Oct; 94(4):750-9. PubMed ID: 16270626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence and risk factors for venous thromboembolism].
    Oger E; Mottier D
    Rev Prat; 2007 Apr; 57(7):711-3, 716, 719-20. PubMed ID: 17626316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty.
    Chotanaphuti T; Ongnamthip P; Silpipat S; Foojareonyos T; Roschan S; Reumthantong A
    J Med Assoc Thai; 2007 Jul; 90(7):1342-7. PubMed ID: 17710975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism in Thai children.
    Sirachainan N; Chuansumrit A; Angchaisuksiri P; Pakakasama S; Hongeng S; Kadegasem P
    Pediatr Hematol Oncol; 2007 Jun; 24(4):245-56. PubMed ID: 17613867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism: application and effectiveness of the American College of Chest Physicians 2001 guidelines for prophylaxis.
    Steier KJ; Singh G; Ullah A; Maneja J; Ha RS; Khan F
    J Am Osteopath Assoc; 2006 Jul; 106(7):388-95. PubMed ID: 16912336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden.
    Couturaud F; Kearon C; Leroyer C; Mercier B; Abgrall JF; Le Gal G; Lacut K; Oger E; Bressollette L; Ferec C; Lamure M; Mottier D;
    Thromb Haemost; 2006 Dec; 96(6):744-9. PubMed ID: 17139368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
    Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D;
    Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of factor V Leiden in surgical patients with symptomatic venous thromboembolism despite prophylaxis.
    Baba-Ahmed M; Le Gal G; Couturaud F; Lacut K; Oger E; Leroyer C
    Thromb Haemost; 2007 Feb; 97(2):171-5. PubMed ID: 17264942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
    Alcalay A; Wun T; Khatri V; Chew HK; Harvey D; Zhou H; White RH
    J Clin Oncol; 2006 Mar; 24(7):1112-8. PubMed ID: 16505431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism in the beta2-adrenergic receptor and lipoprotein lipase genes as risk determinants for idiopathic venous thromboembolism: a multilocus, population-based, prospective genetic analysis.
    Zee RY; Cook NR; Cheng S; Erlich HA; Lindpaintner K; Ridker PM
    Circulation; 2006 May; 113(18):2193-200. PubMed ID: 16651467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) in 5 Gulf countries.
    Al Sayegh F; Almahmeed W; Al Humood S; Marashi M; Bahr A; Al Mahdi H; Bakir S; Al Farhan M
    Clin Appl Thromb Hemost; 2009; 15(3):289-96. PubMed ID: 18400764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism in ovarian cancer.
    Rodriguez AO; Wun T; Chew H; Zhou H; Harvey D; White RH
    Gynecol Oncol; 2007 Jun; 105(3):784-90. PubMed ID: 17408726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
    Chew HK; Wun T; Harvey DJ; Zhou H; White RH
    J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study.
    van Vlijmen EF; Brouwer JL; Veeger NJ; Eskes TK; de Graeff PA; van der Meer J
    Arch Intern Med; 2007 Feb; 167(3):282-9. PubMed ID: 17296885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
    Strandberg K; Svensson PJ; Ohlin AK
    Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study.
    Glynn RJ; Ridker PM; Goldhaber SZ; Zee RY; Buring JE
    Circulation; 2007 Sep; 116(13):1497-503. PubMed ID: 17846285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.